A guide to AIM stocks: everything you should know about AIM
AIM stocks account for a large percentage of retail trading as, despite the risks, there is an excitement to the market’s volatility. Find out everything you need to know about the AIM stock exchange and how you can take a position on AIM stocks with us.
Share this:
Who are the AIM Nomads?
AIM Nomads are the ‘nominated advisors’ that act as gatekeepers, advisers and regulators of all companies that are listing, or have listed, on the market. Each AIM company has its own Nomad that will continue to assist it throughout its time on the market.
The system of nomads has been widely criticised because these individuals are paid fees by the companies, so arguably have little incentive to impose regulations upon them. There have been plenty of instances of nomads failing in their duties and cases of outright fraud.
How to trade AIM stocks
You can trade AIM stocks either by buying and selling the shares of individual companies listed on AIM, or via ETFs and investment trusts that hold the underlying AIM stocks. The latter method would enable you to get a much broader exposure to the market.
Whichever way you decide to take a position, follow these steps to get started:
- Open a FOREX.com account, or log in if you’re already a customer
- Search for the market you want to trade
- Choose your position and size, and your stop and limit levels
- Enter your trade and monitor the market
Alternatively, you can practise trading AIM stocks and ETFs with a risk-free demo account.
AIM shares
Trading the shares of AIM-listed companies via CFDs enables you to profit from both periods of growth and decline. If you think a company’s value is going to rise, you’d opt to ‘buy’ the market – known as going long – and if you thought it was going to fall, you’d ‘sell’ or go short.
As mentioned, the AIM shares available to you include mid-cap firms like Asos, Boohoo.com and FeverTree, as well as the smaller-cap stocks the market is known for.
Learn more about share trading with us.
AIM ETFs and investment trusts
When you buy a share in an ETF or an investment trusts, you’ll be getting exposure a basket of AIM stocks from a single position. If AIM company shares increased in value, the ETF or trust would profit and so would you. But if AIM shares decreased, you’d experience a loss.
You can trade on AIM ETFs and investment trusts with us via CFDs – these derivatives enable you to go both long and short.
For example, you could trade the iShares MSCI UK Small Cap, an ETF that seeks to track the performance of the MSCI UK Small Cap Index but also offers protection by investing in some FTSE 100 stocks too. Or you could buy and sell shares of Montanaro UK Smaller Companies Investment Trust, which aims to achieve growth by investing in small cap companies listed on the LSE Main Market and AIM.
Latest market news
Open an account in minutes
Experience award-winning platforms with fast and secure execution, and enjoy tight spreads from 0.5 pts on FX and 0.3 pts on indices.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
ASX 200 Slides as Oil, Yields and Rate Risks Hit Sentiment
The ASX 200 suffered its worst week in six months as surging oil, higher bond yields and renewed rate-hike bets drove a broad risk-off move.
DeepSeek IPO: Everything You Need to Know About DeepSeek
DeepSeek IPO: Learn about its potential 2027 listing, valuation, revenue, profitability, ownership, competitors and what investors should watch.
S&P 500, Nasdaq, Dow Forecast: Rising Yields Test Rally Ahead of Nvidia, Fed 8 22 2026
S&P 500, Nasdaq and Dow test key technical levels as momentum fades, raising the risk of a deeper correction heading into a pivotal week.
This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.
StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.
In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.
StoneX Financial Pte. Ltd. is not under any obligation to update this report.
Trading CFDs carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit www.forex.com/en-sg/terms-and-policies for the complete Risk Disclosure Statement.